Serum CA 125 in acute pelvic inflammatory disease
- 1 May 1989
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 96 (5) , 574-579
- https://doi.org/10.1111/j.1471-0528.1989.tb03259.x
Abstract
Summary. Serum levels of CA 125 and other selected tumour markers were measured in 31 patients with proven pelvic inflammatory disease (PID). Ten (32%) of the patients had elevated CA 125, one (4%) had elevated CEA, and none had elevated CA 15–3, AFP or β2‐micro‐globulin. Compared to patients with normal CA 125, patients with elevated CA 125 were older, more often users of intrauterine contraceptive devices, had longer duration of symptoms, higher erythrocyte sedimentation rates, and more often had an adnexal mass on pelvic examination. There was a correlation between CA 125 levels and the severity of adnexal inflammation as defined by laparoscopy. Isolation of specific micro‐organisms from the upper genital tract was not associated with elevated CA 125. In most women serum levels of CA 125 decreased during treatment. PID should be considered as a major cause of positive CA 125 findings among young women.This publication has 22 references indexed in Scilit:
- The clinical significance of pre-operative serum CA 125 in ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- CA-125 in gynecological malignanciesEuropean Journal of Cancer and Clinical Oncology, 1987
- Microbiological and histopathological findings in acute pelvic inflammatory diseaseBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- The value of CA 125 serum assay in the management of ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Elevated serum concentrations of CA-125 in patients with advanced endometriosisFertility and Sterility, 1986
- Serum C-reactive protein determination in acute pelvic inflammatory diseaseAmerican Journal of Obstetrics and Gynecology, 1986
- Tumour‐associated antigen CA 125 in patients with ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixAmerican Journal of Obstetrics and Gynecology, 1984
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Objectivized diagnosis of acute pelvic inflammatory diseaseAmerican Journal of Obstetrics and Gynecology, 1969